Publications by authors named "Jonathan R Buggisch"

Claim this Profile
S
Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies.
Gabriel Ramos Arias, Rémy Sindayigaya, Mehdi Ouaissi, Jonathan R Buggisch, Maximilian Schmeding

Ann Surg Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and technical validation of an ultrasound nebulizer to deliver intraperitoneal pressurized aerosols in a rat colon cancer peritoneal metastases model.
Jonathan R Buggisch, Daniel Göhler, Julien Sobilo, Stéphanie Lerondel, Günther A Rezniczek

BMC Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
Rémy Sindayigaya, Can Dogan, Cédric Remy Demtröder, Britta Fischer, Elias Karam, Jonathan Robin Buggisch

Ann Surg Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a rat capnoperitoneum phantom to study drug aerosol deposition in the context of anticancer research on peritoneal carcinomatosis.
Daniel Göhler, Antje Geldner, Ralf Gritzki, Franz Lohse, Stephan Große, Jonathan R Buggisch

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Model to Test Electrostatic Precipitation Technology in the COVID-19 Era: A Pilot Study.
Jonathan R Buggisch, Daniel Göhler, Alain Le Pape, Sébastien Roger, Mehdi Ouaissi

J Am Coll Surg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis